Levetiracetam is a drug used in the treatment of epilepsy. More specifically, the drug is used to treat partial onset (from patients over 4), myoclonic (in patients over 12), and tonic-clonic seizures (in patients over 6).
Levetiracetam works as a neuromodulator, modulating the nerve impulses crossing the brain. The precise mechanism by which levetiracetam achieves this effect is currently unknown.
The drug is available in both oral and intravenous routes and is primarily metabolised in the liver. It has a moderate half-life of around 6 hours (meaning 75 percent of the drug has left the body after 12 hours).
Common side effects with levetiracetam include dizziness, weakness, appetite loss, stuffy nose, and fatigue.